The PurpleLab^® Resource Center

This research, led by Grace K. Kane, Douglas Londono, and Nathan J. Markward, explores how the timing of biomarker testing affects survival outcomes in patients with non-small cell lung cancer (NSCLC). Using real-world claims data, it identifies disparities in testing and treatment patterns and their impact on mortality rates. Biomarker testing is essential to advancing…

Upping the Migraine Intelligence Quotient: Real-world data sheds light on prevalence rates, providers and treatment variation Life Sciences  Introduction Headache disorders including migraine are highly prevalent globally, estimated to affect more than 50% of the population at any point and time. In the U.S., migraine patients spend an average of $9,000 more than those without…

PurpleLab®, a leading provider of real-world healthcare claims data in the US, and Comscore, a global leader in measuring and analyzing consumer behavior, today announced a strategic partnership to make PurpleLab’s robust healthcare targeting segments available as ID-free Predictive Audiences directly on The Trade Desk’s Contextual Marketplace.  The partnership addresses the changes to state privacy…